VABOMERE

Peak

meropenem-vaborbactam

NDAINTRAVENOUSPOWDERPriority Review

Approved

Aug 2017

Lifecycle

Peak

Competitive Pressure

0/100

Mechanism of Action

beta Lactamase Inhibitors

Pharmacologic Class:

beta Lactamase Inhibitor

Loss of Exclusivity

LOE Date

May 20, 2039

160 months away

Patent Expiry

May 20, 2039

Exclusivity Expiry

Aug 29, 2027

Patent Records (5)

Patent #	Expiry	Type	Use Code
9694025	Aug 8, 2031		U-2120
10183034	Aug 8, 2031		U-2490
10561675	Aug 8, 2031		U-2490
11007206	Aug 8, 2031		U-3128
12171772	Aug 8, 2031	Substance	—

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers